MedPath

To look if post dilatation after stenting has role in patients with ST elevated Myocardial infarctio

Not Applicable
Conditions
Health Condition 1: I213- ST elevation (STEMI) myocardial infarction of unspecified site
Registration Number
CTRI/2020/08/027313
Lead Sponsor
PGIMER
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Age > 18 years

Gives consent

Acute case of ST elevated Myocardial Infarction with indication for revascularization

After stent deployment, patient should be eligible for either group.

Exclusion Criteria

Pregnancy

Patient with malignancy

Severe left main disease

Cardiogenic shock

Haemody¬namic instability

Bypass graft lesions

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
1.To compare clinical, biochemical and angiographic profile of ST elevated Myocardial Infarction patients undergoing PCI with or without post dilatationTimepoint: Patient will be assessed every month for 6 months and TMT will be done after 3 months
Secondary Outcome Measures
NameTimeMethod
To compare outcome of stent post dilatation in patients with ST elevated Myocardial Infarction. <br/ ><br>Primary Endpoint: Target Vessel Revascularisation (TVR) i.e Stent Thrombosis and ISR <br/ ><br>Secondary Endpoints: MACE like Heart failure, stroke, ischemic cardiovascular events and death <br/ ><br>Timepoint: Symptoms will be assessed for every month for 6 month and TMT will be done at 3 months
© Copyright 2025. All Rights Reserved by MedPath